Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Taiwan Equity Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹20.0393₹22.8170
NAV date20 Nov 202620 Nov 2026
History4.9 years3.1 years
Expense ratio2.5%2.1%
Stars★★★★★★★★★★
Growth Score64.7093.90

Returns

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
1 month−38.49%+12.87%
3 months−41.06%+6.85%
6 months−39.61%+17.20%
YTD+11.29%+32.43%
1 year+20.53%+30.73%
3 years (CAGR)+29.29%+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch+15.70%+30.28%

Risk

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Volatility42.3%15.8%
Downside volatility27.0%8.6%
Sharpe0.541.44
Sortino0.842.64
Calmar0.621.94
Return / risk0.691.85
Deepest fall−47.41%−15.07%
Days to recover—133
Below its high−47.41%+0.00%

Against benchmark

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Alpha+29.47%+6.36%
Beta−0.130.97
R²0.3%85.0%
Up capture60.3%106.7%
Down capture−66.8%74.4%
Tracking error46.0%6.1%
Information ratio0.510.97
Treynor−1.710.22

Consistency

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
Best 1-year+274.26%+64.96%
Middle 1-year+33.10%+21.84%
Worst 1-year−34.66%+0.52%
1-year periods with a loss15.1%0.0%
Middle 3-year+37.24%+28.68%
Positive months66.7%69.4%
Best day+16.58%+3.19%
Worst day−8.89%−3.62%
Worst 5% day−3.90%−1.50%
Positive days56.5%58.1%
NAVs a year233247

SIP of ₹10,000 a month

Nippon India Taiwan Equity FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+26.14%+26.26%
1-year XIRR−31.95%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth